MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

ECAP-Controlled Closed-Loop SCS Alleviates Neuropathic Pain and Improves Motor Function in a Patient Suffering from Parkinson’s Disease and Radicular Pain

Z. Zamfirov, D. Mugan, G. Ahluwalia (Annapolis, USA)

Meeting: 2024 International Congress

Abstract Number: 883

Keywords: Neurostimulation, Pain, Parkinson’s

Category: Parkinson’s Disease: Pharmacology and Therapy

Objective: The objective of this case report is to highlight the effect of a new technology, Evoked Compound Action Potential (ECAP) controlled closed-loop spinal cord stimulation (SCS), on neuropathic pain and motor control in a Parkinson’s Disease patient suffering from radicular pain

Background: SCS is a commonly used treatment of last resort, to manage refractory neuropathic pain. The most recent advance in the field of SCS is the introduction of ECAP sensing and automated amplitude modulation by using the ECAP as a control variable in a closed-loop system. Several case reports, and prospective case series,  investigated the use of SCS to improve function in patients with Parkinson’s Disease (PD). Mostly these reports have focused on changes to Freezing of Gate (FoG) symptoms. Herein, we present a case report of improved motor function following the application of ECAP-controlled closed-loop SCS for the management of radicular pain in a patient with concomitant PD

Method: A retrospective case report of a single patient’s experience of improvement in both pain and PD symptoms following the application of ECAP-controlled closed-loop SCS. In an attempt to differentiate the effect of SCS on gait improvements from the pain effect, walking tasks were recorded with stimulation turned on and off

Results: Two, 12-contact SCS leads were implanted in the posterior epidural space spanning the lower thoracic spinal cord (T8-T11). ECAP-controlled closed-loop stimulation was delivered to provide a stimulation-induced sensation (paresthesia) in both legs, predominantly covering the most painful limb. 3-months post-implantation leg pain intensity was reduced from 9/10 to 0/10 (verbal rating scale 0-10). Our patient, who was wheelchair-bound prior to implantation of the SCS system, can now walk without assistance. Acute deactivation of the SCS system caused a reduction in muscle strength and walking speed while the radicular remained still suppressed*

*If accepted for presentation stimulation on/off videos will be shown

Conclusion: This anecdotal report of motor improvements following low thoracic ECAP-controlled closed-loop SCS provides a further small signal that SCS may offer some clinical utility for the management of motor symptoms associated with PD. A prospective study in PD patients in whom pain is not a significant co-morbidity would be a useful next step

To cite this abstract in AMA style:

Z. Zamfirov, D. Mugan, G. Ahluwalia. ECAP-Controlled Closed-Loop SCS Alleviates Neuropathic Pain and Improves Motor Function in a Patient Suffering from Parkinson’s Disease and Radicular Pain [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/ecap-controlled-closed-loop-scs-alleviates-neuropathic-pain-and-improves-motor-function-in-a-patient-suffering-from-parkinsons-disease-and-radicular-pain/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/ecap-controlled-closed-loop-scs-alleviates-neuropathic-pain-and-improves-motor-function-in-a-patient-suffering-from-parkinsons-disease-and-radicular-pain/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley